This was an early-phase, open-label pilot study in pregnant women with chronic kidney disease and high blood pressure. Sample size was small (single-center, low double-digit number of participants). Women received daily beetroot juice containing a standardized amount of dietary nitrate during pregnancy, with serial blood pressure readings and blood/urine tests. Primary endpoints included safety (maternal and fetal), changes in blood pressure, and biomarkers of nitric oxide availability and vascular function.
Daily beetroot juice led to a measurable rise in plasma nitrate/nitrite levels, indicating improved nitric oxide availability. Many participants experienced modest reductions in blood pressure, particularly in diastolic pressure, though the study was not powered to show firm statistical conclusions on clinical outcomes. No major safety signals or clear harm to fetal growth or pregnancy outcomes were reported over the study period. Kidney function and routine pregnancy monitoring remained broadly stable, but the small sample and design limit certainty.
This was a small, early-phase, non-randomized study without a placebo group, so improvements could be due to other factors (medication changes, diet, rest, or natural variation). Short follow-up and limited numbers mean rare adverse events, longer-term kidney effects, and subtle fetal/child developmental impacts could be missed. Participants were a specific high-risk group (pregnant women with CKD and hypertension in a specialized center), so results may not apply to all pregnant women or to those without kidney disease. Dose of nitrate, quality of beetroot products, individual gut microbiome differences, and background diet may all influence response, and the study does not clarify optimal dose, timing, or which patients benefit most.
The study suggests that dietary nitrate from beetroot juice may be a feasible, non-drug strategy to support blood pressure control and vascular function in pregnant women with CKD, a high‑risk group with limited medication options. Methodological strengths include targeted biomarker assessment and close maternal–fetal monitoring, but the open-label design, lack of a control group, and small sample greatly weaken causal conclusions. These findings align with prior non-pregnant data showing beetroot-derived nitrate can improve endothelial function and reduce blood pressure, extending the concept into a pregnancy-CKD setting. However, this remains hypothesis-generating, and it does not override current guideline-based antihypertensive and renal care, nor does it resolve concerns about long‑term nitrate exposure and individual variability in response.
For women with CKD in pregnancy, this study points to dietary nitrate (from beetroot) as a potential future tool to support blood pressure and blood vessel health, but it is not ready as a stand‑alone treatment. Within a restorative framework, it reinforces the importance of vascular health, kidney function, and placental blood flow as root drivers of pregnancy and fertility outcomes. Patients should not self-prescribe concentrated beetroot juice in pregnancy; any consideration should be part of a coordinated plan with obstetrics, nephrology, and nutrition. Emphasis remains on blood pressure monitoring, kidney-friendly nutrition, tracking cycle and pregnancy biomarkers, and addressing inflammation, metabolic health, and underlying hypertensive drivers.
This research looked at whether beetroot juice, which is rich in natural nitrate, could gently lower blood pressure and improve blood flow for pregnant women who already have kidney disease. Healthier blood flow may help both the mother’s kidneys and the baby’s placenta, which are key for a safe pregnancy and future fertility. The study suggests this approach might help, and it did not show obvious harm, but the group was very small and closely monitored. This is not a do‑it‑yourself remedy—if you are pregnant or planning pregnancy with kidney problems or high blood pressure, any change in supplements or diet should be planned with your medical team, alongside careful root‑cause workup of blood pressure, kidney health, and inflammation.
Pilot data indicate that standardized dietary nitrate from beetroot juice can increase plasma nitrate/nitrite and may modestly reduce BP in pregnant women with CKD, without short-term safety concerns. Consideration: in selected, well-monitored patients, dietary nitrate could become an adjunct to established antihypertensives, particularly when medication options are constrained by pregnancy. For restorative care, integrate assessment of: BP patterns (including home readings), eGFR and proteinuria, endothelial function proxies (uric acid, hs-CRP, possibly arginine/ADMA where available), metabolic and inflammatory status, and placental function markers (uterine artery Doppler where indicated, fetal growth curves). If future, more robust trials confirm benefit, protocols would need standardized nitrate dosing, attention to oral microbiome (since nitrate reduction is saliva-dependent), monitoring for methemoglobinemia in susceptible individuals, and alignment with kidney-friendly nutritional plans. Until then, treat beetroot juice as experimental and avoid routine recommendation outside research or highly individualized, documented shared decision-making.
Educational insights, not a diagnosis or individualized treatment advice. Discuss findings with your own clinician. Visit Reproductive Health Insights to explore fertility resources.